非経口栄養市場レポート：栄養タイプ、エンドユーザー、地域別、2024～2032年

世界の非経口栄養市場規模は2023年に72億米ドルに達しました。今後、IMARC Groupは、市場は2032年までに122億米ドルに達し、2024～2032年の間に5.9％の成長率（CAGR）を示すと予測しています。

非経口栄養（PN）または静脈栄養は、脂肪、タンパク質、ビタミン、ミネラル、炭水化物、電解質などの液体栄養を記載しています。これは、消化管を利用できない患者に栄養サポートを提供する特殊な栄養療法の一部です。栄養失調を予防し、エネルギー、水分、体力のレベルを維持するのに役立ちます。そのため、がん、クローン病、短腸症候群、虚血性腸疾患、腸機能異常などの患者に広く用いられています。

非経口栄養市場傾向

栄養不良の有病率の上昇、出生率の上昇、早産児の増加は、世界中でPNの需要を喚起している主要要因のひとつです。さらに、喘息、白血病、結核、気管支炎、水疱瘡、貧血などの小児疾患を患う患者数が大幅に増加しています。このことは、比較的慢性疾患にかかりやすい高齢者人口の増加とともに、PN製品の需要にもプラスの影響を与えています。さらに、ファストフードの消費の増加は、高血圧、糖尿病、肥満、その他の代謝異常などの非伝染性疾患の増加をもたらしています。これは、肝不全、腎不全、タンパク質・エネルギー栄養失調の罹患率の上昇と相まって、アムニオ酸を豊富に含む非経口製品の消費を増加させています。市場はさらに、脂質エマルションの最適化や間接熱量測定の活用など、PNにおける大幅な改善によって牽引されています。その他にも、各国の行政機関や民間団体による医療セクター全体の開拓への支出の増加や、医療セクターによるPN製品の採用の増加といった要因もあり、世界中で市場の成長が強化されると予測されています。

本レポートで扱う主要質問

• 世界の非経口栄養市場の市場規模は？
• 2024～2032年における世界の非経口栄養市場の予想成長率は？
• 世界の非経口栄養市場を牽引する主要因は何か？
• 世界の非経口栄養市場に対するCOVID-19の影響は？
• 世界の非経口栄養市場の栄養タイプ別内訳は？
• 世界の非経口栄養市場のエンドユーザー別内訳は？
• 世界の非経口栄養市場の主要地域は？
• 世界の非経口栄養市場における主要参入企業/企業は？

目次

第1章 序文

第2章 調査範囲と調査手法

• 調査の目的
• ステークホルダー
• データソース
  • 一次情報
  • 二次情報
• 市場推定
  • ボトムアップアプローチ
  • トップダウンアプローチ
• 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

• 概要
• 主要業界動向

第5章 世界の非経口栄養市場

• 市場概要
• 市場実績
• COVID-19の影響
• 市場予測

第6章 市場内訳：栄養素タイプ別

• 炭水化物
• 脂質乳剤
• 単回投与アミノ酸溶液
• 微量元素
• ビタミンとミネラル

第7章 市場内訳：エンドユーザー別

• 病院
• クリニック
• その他

第8章 市場内訳：地域別

• 北米
  • 米国
  • カナダ
• アジア太平洋
  • 中国
  • 日本
  • インド
  • 韓国
  • オーストラリア
  • インドネシア
  • その他
• 欧州
  • ドイツ
  • フランス
  • 英国
  • イタリア
  • スペイン
  • ロシア
  • その他
• ラテンアメリカ
  • ブラジル
  • メキシコ
  • その他
• 中東・アフリカ
  • 市場動向
  • 市場内訳：国別
  • 市場予測

第9章 SWOT分析

• 概要
• 強み
• 弱み
• 機会
• 脅威

第10章 バリューチェーン分析

第11章 ポーターのファイブフォース分析

• 概要
• 買い手の交渉力
• 供給企業の交渉力
• 競合の程度
• 新規参入業者の脅威
• 代替品の脅威

第12章 価格分析

第13章 競合情勢

• 市場構造
• 主要企業
• 主要企業のプロファイル
  • Aculife Healthcare Private Limited
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Fresenius SE & Co. KGaA
  • Grifols S.A.
  • Otsuka Pharmaceutical Factory Inc.
  • Pfizer Inc.
  • Servona GmbH

List of Figures

• Figure 1: Global: Parenteral Nutrition Market: Major Drivers and Challenges
• Figure 2: Global: Parenteral Nutrition Market: Sales Value (in Billion US$), 2018-2023
• Figure 3: Global: Parenteral Nutrition Market Forecast: Sales Value (in Billion US$), 2024-2032
• Figure 4: Global: Parenteral Nutrition Market: Breakup by Nutrient Type (in %), 2023
• Figure 5: Global: Parenteral Nutrition Market: Breakup by End User (in %), 2023
• Figure 6: Global: Parenteral Nutrition Market: Breakup by Region (in %), 2023
• Figure 7: Global: Parenteral Nutrition (Carbohydrates) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 8: Global: Parenteral Nutrition (Carbohydrates) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 9: Global: Parenteral Nutrition (Lipid Emulsion) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 10: Global: Parenteral Nutrition (Lipid Emulsion) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 11: Global: Parenteral Nutrition (Single Dose Amino Acid Solution) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 12: Global: Parenteral Nutrition (Single Dose Amino Acid Solution) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 13: Global: Parenteral Nutrition (Trace Elements) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 14: Global: Parenteral Nutrition (Trace Elements) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 15: Global: Parenteral Nutrition (Vitamins and Minerals) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 16: Global: Parenteral Nutrition (Vitamins and Minerals) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 17: Global: Parenteral Nutrition (Hospitals) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 18: Global: Parenteral Nutrition (Hospitals) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 19: Global: Parenteral Nutrition (Clinics) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 20: Global: Parenteral Nutrition (Clinics) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 21: Global: Parenteral Nutrition (Other End Users) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 22: Global: Parenteral Nutrition (Other End Users) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 23: North America: Parenteral Nutrition Market: Sales Value (in Million US$), 2018 & 2023
• Figure 24: North America: Parenteral Nutrition Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 25: United States: Parenteral Nutrition Market: Sales Value (in Million US$), 2018 & 2023
• Figure 26: United States: Parenteral Nutrition Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 27: Canada: Parenteral Nutrition Market: Sales Value (in Million US$), 2018 & 2023
• Figure 28: Canada: Parenteral Nutrition Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 29: Asia-Pacific: Parenteral Nutrition Market: Sales Value (in Million US$), 2018 & 2023
• Figure 30: Asia-Pacific: Parenteral Nutrition Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 31: China: Parenteral Nutrition Market: Sales Value (in Million US$), 2018 & 2023
• Figure 32: China: Parenteral Nutrition Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 33: Japan: Parenteral Nutrition Market: Sales Value (in Million US$), 2018 & 2023
• Figure 34: Japan: Parenteral Nutrition Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 35: India: Parenteral Nutrition Market: Sales Value (in Million US$), 2018 & 2023
• Figure 36: India: Parenteral Nutrition Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 37: South Korea: Parenteral Nutrition Market: Sales Value (in Million US$), 2018 & 2023
• Figure 38: South Korea: Parenteral Nutrition Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 39: Australia: Parenteral Nutrition Market: Sales Value (in Million US$), 2018 & 2023
• Figure 40: Australia: Parenteral Nutrition Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 41: Indonesia: Parenteral Nutrition Market: Sales Value (in Million US$), 2018 & 2023
• Figure 42: Indonesia: Parenteral Nutrition Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 43: Others: Parenteral Nutrition Market: Sales Value (in Million US$), 2018 & 2023
• Figure 44: Others: Parenteral Nutrition Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 45: Europe: Parenteral Nutrition Market: Sales Value (in Million US$), 2018 & 2023
• Figure 46: Europe: Parenteral Nutrition Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 47: Germany: Parenteral Nutrition Market: Sales Value (in Million US$), 2018 & 2023
• Figure 48: Germany: Parenteral Nutrition Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 49: France: Parenteral Nutrition Market: Sales Value (in Million US$), 2018 & 2023
• Figure 50: France: Parenteral Nutrition Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 51: United Kingdom: Parenteral Nutrition Market: Sales Value (in Million US$), 2018 & 2023
• Figure 52: United Kingdom: Parenteral Nutrition Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 53: Italy: Parenteral Nutrition Market: Sales Value (in Million US$), 2018 & 2023
• Figure 54: Italy: Parenteral Nutrition Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 55: Spain: Parenteral Nutrition Market: Sales Value (in Million US$), 2018 & 2023
• Figure 56: Spain: Parenteral Nutrition Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 57: Russia: Parenteral Nutrition Market: Sales Value (in Million US$), 2018 & 2023
• Figure 58: Russia: Parenteral Nutrition Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 59: Others: Parenteral Nutrition Market: Sales Value (in Million US$), 2018 & 2023
• Figure 60: Others: Parenteral Nutrition Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 61: Latin America: Parenteral Nutrition Market: Sales Value (in Million US$), 2018 & 2023
• Figure 62: Latin America: Parenteral Nutrition Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 63: Brazil: Parenteral Nutrition Market: Sales Value (in Million US$), 2018 & 2023
• Figure 64: Brazil: Parenteral Nutrition Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 65: Mexico: Parenteral Nutrition Market: Sales Value (in Million US$), 2018 & 2023
• Figure 66: Mexico: Parenteral Nutrition Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 67: Others: Parenteral Nutrition Market: Sales Value (in Million US$), 2018 & 2023
• Figure 68: Others: Parenteral Nutrition Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 69: Middle East and Africa: Parenteral Nutrition Market: Sales Value (in Million US$), 2018 & 2023
• Figure 70: Middle East and Africa: Parenteral Nutrition Market: Breakup by Country (in %), 2023
• Figure 71: Middle East and Africa: Parenteral Nutrition Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 72: Global: Parenteral Nutrition Industry: SWOT Analysis
• Figure 73: Global: Parenteral Nutrition Industry: Value Chain Analysis
• Figure 74: Global: Parenteral Nutrition Industry: Porter's Five Forces Analysis

List of Tables

• Table 1: Global: Parenteral Nutrition Market: Key Industry Highlights, 2023 and 2032
• Table 2: Global: Parenteral Nutrition Market Forecast: Breakup by Nutrient Type (in Million US$), 2024-2032
• Table 3: Global: Parenteral Nutrition Market Forecast: Breakup by End User (in Million US$), 2024-2032
• Table 4: Global: Parenteral Nutrition Market Forecast: Breakup by Region (in Million US$), 2024-2032
• Table 5: Global: Parenteral Nutrition Market: Competitive Structure
• Table 6: Global: Parenteral Nutrition Market: Key Players

The global parenteral nutrition market size reached US$ 7.2 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 12.2 Billion by 2032, exhibiting a growth rate (CAGR) of 5.9% during 2024-2032.

Parenteral nutrition (PN), or intravenous feeding, offers liquid nutrients like fats, proteins, vitamins, minerals, carbohydrates, and electrolytes. It is a part of specialized nutritional therapy that providing nutritional support to patients who are unable to utilize their gastrointestinal tract. It aids in preventing malnutrition and maintaining energy, hydration, and strength levels. As a result, it is widely used among patients who are suffering from cancer, Crohn's disease, short bowel syndrome, ischemic bowel disease, and abnormal bowel function.

Parenteral Nutrition Market Trends:

The rising prevalence of malnutrition, growing natality rate, and increasing premature births are among the primary factors catalyzing the demand for PN around the world. Moreover, there is a considerable rise in the number of individuals experiencing pediatric disorders, such as asthma, leukemia, tuberculosis, bronchitis, chickenpox, and anemia. This, along with the rising geriatric population, which is relatively more prone to chronic diseases, is also influencing the demand for PN products positively. Furthermore, the growing consumption of fast food has resulted in the growing instances of non-communicable diseases like hypertension, diabetes, obesity, and other metabolic disorders. This, in confluence with the rising incidences of hepatic insufficiency, renal insufficiency and protein-energy malnutrition, is increasing the consumption of amnio acid-rich and parenteral products. The market is further driven by significant improvements in the PN, such as lipid emulsions optimizations and utilization of indirect calorimetry. Some of the other factors, such as increasing expenditure on the overall development of the healthcare sector by the governing agencies and private entities of several countries and rising adoption of PN products by the healthcare sector, are anticipated to strengthen the market growth across the globe.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global parenteral nutrition market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on nutrient type and end user.

Breakup by Nutrient Type:

Carbohydrates

Lipid Emulsion

Single Dose Amino Acid Solution

Trace Elements

Vitamins and Minerals

Breakup by End User:

Hospitals

Clinics

Others

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Aculife Healthcare Private Limited, B. Braun Melsungen AG, Baxter International Inc., Fresenius SE & Co. KGaA, Grifols S.A., Otsuka Pharmaceutical Factory Inc., Pfizer Inc. and Servona GmbH.

Key Questions Answered in This Report

• 1. How big is the global parenteral nutrition market?
• 2. What is the expected growth rate of the global parenteral nutrition market during 2024-2032?
• 3. What are the key factors driving the global parenteral nutrition market?
• 4. What has been the impact of COVID-19 on the global parenteral nutrition market?
• 5. What is the breakup of the global parenteral nutrition market based on the nutrient type?
• 6. What is the breakup of the global parenteral nutrition market based on the end user?
• 7. What are the key regions in the global parenteral nutrition market?
• 8. Who are the key players/companies in the global parenteral nutrition market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Parenteral Nutrition Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Forecast

6 Market Breakup by Nutrient Type

• 6.1 Carbohydrates
  • 6.1.1 Market Trends
  • 6.1.2 Market Forecast
• 6.2 Lipid Emulsion
  • 6.2.1 Market Trends
  • 6.2.2 Market Forecast
• 6.3 Single Dose Amino Acid Solution
  • 6.3.1 Market Trends
  • 6.3.2 Market Forecast
• 6.4 Trace Elements
  • 6.4.1 Market Trends
  • 6.4.2 Market Forecast
• 6.5 Vitamins and Minerals
  • 6.5.1 Market Trends
  • 6.5.2 Market Forecast

7 Market Breakup by End User

• 7.1 Hospitals
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 Clinics
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast
• 7.3 Others
  • 7.3.1 Market Trends
  • 7.3.2 Market Forecast

8 Market Breakup by Region

• 8.1 North America
  • 8.1.1 United States
    • 8.1.1.1 Market Trends
    • 8.1.1.2 Market Forecast
  • 8.1.2 Canada
    • 8.1.2.1 Market Trends
    • 8.1.2.2 Market Forecast
• 8.2 Asia-Pacific
  • 8.2.1 China
    • 8.2.1.1 Market Trends
    • 8.2.1.2 Market Forecast
  • 8.2.2 Japan
    • 8.2.2.1 Market Trends
    • 8.2.2.2 Market Forecast
  • 8.2.3 India
    • 8.2.3.1 Market Trends
    • 8.2.3.2 Market Forecast
  • 8.2.4 South Korea
    • 8.2.4.1 Market Trends
    • 8.2.4.2 Market Forecast
  • 8.2.5 Australia
    • 8.2.5.1 Market Trends
    • 8.2.5.2 Market Forecast
  • 8.2.6 Indonesia
    • 8.2.6.1 Market Trends
    • 8.2.6.2 Market Forecast
  • 8.2.7 Others
    • 8.2.7.1 Market Trends
    • 8.2.7.2 Market Forecast
• 8.3 Europe
  • 8.3.1 Germany
    • 8.3.1.1 Market Trends
    • 8.3.1.2 Market Forecast
  • 8.3.2 France
    • 8.3.2.1 Market Trends
    • 8.3.2.2 Market Forecast
  • 8.3.3 United Kingdom
    • 8.3.3.1 Market Trends
    • 8.3.3.2 Market Forecast
  • 8.3.4 Italy
    • 8.3.4.1 Market Trends
    • 8.3.4.2 Market Forecast
  • 8.3.5 Spain
    • 8.3.5.1 Market Trends
    • 8.3.5.2 Market Forecast
  • 8.3.6 Russia
    • 8.3.6.1 Market Trends
    • 8.3.6.2 Market Forecast
  • 8.3.7 Others
    • 8.3.7.1 Market Trends
    • 8.3.7.2 Market Forecast
• 8.4 Latin America
  • 8.4.1 Brazil
    • 8.4.1.1 Market Trends
    • 8.4.1.2 Market Forecast
  • 8.4.2 Mexico
    • 8.4.2.1 Market Trends
    • 8.4.2.2 Market Forecast
  • 8.4.3 Others
    • 8.4.3.1 Market Trends
    • 8.4.3.2 Market Forecast
• 8.5 Middle East and Africa
  • 8.5.1 Market Trends
  • 8.5.2 Market Breakup by Country
  • 8.5.3 Market Forecast

9 SWOT Analysis

• 9.1 Overview
• 9.2 Strengths
• 9.3 Weaknesses
• 9.4 Opportunities
• 9.5 Threats

10 Value Chain Analysis

11 Porters Five Forces Analysis

• 11.1 Overview
• 11.2 Bargaining Power of Buyers
• 11.3 Bargaining Power of Suppliers
• 11.4 Degree of Competition
• 11.5 Threat of New Entrants
• 11.6 Threat of Substitutes

12 Price Analysis

13 Competitive Landscape

• 13.1 Market Structure
• 13.2 Key Players
• 13.3 Profiles of Key Players
  • 13.3.1 Aculife Healthcare Private Limited
    • 13.3.1.1 Company Overview
    • 13.3.1.2 Product Portfolio
  • 13.3.2 B. Braun Melsungen AG
    • 13.3.2.1 Company Overview
    • 13.3.2.2 Product Portfolio
    • 13.3.2.3 SWOT Analysis
  • 13.3.3 Baxter International Inc.
    • 13.3.3.1 Company Overview
    • 13.3.3.2 Product Portfolio
    • 13.3.3.3 Financials
    • 13.3.3.4 SWOT Analysis
  • 13.3.4 Fresenius SE & Co. KGaA
    • 13.3.4.1 Company Overview
    • 13.3.4.2 Product Portfolio
    • 13.3.4.3 Financials
    • 13.3.4.4 SWOT Analysis
  • 13.3.5 Grifols S.A.
    • 13.3.5.1 Company Overview
    • 13.3.5.2 Product Portfolio
    • 13.3.5.3 Financials
  • 13.3.6 Otsuka Pharmaceutical Factory Inc.
    • 13.3.6.1 Company Overview
    • 13.3.6.2 Product Portfolio
    • 13.3.6.3 Financials
    • 13.3.6.4 SWOT Analysis
  • 13.3.7 Pfizer Inc.
    • 13.3.7.1 Company Overview
    • 13.3.7.2 Product Portfolio
    • 13.3.7.3 Financials
    • 13.3.7.4 SWOT Analysis
  • 13.3.8 Servona GmbH
    • 13.3.8.1 Company Overview
    • 13.3.8.2 Product Portfolio